CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹7,123 Cr | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr |
What is the latest Operating Profit of CIPLA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹7,123 Cr |
| Mar2025 | ₹6,291 Cr |
| Mar2024 | ₹4,990 Cr |
| Mar2023 | ₹4,512 Cr |
| Mar2022 | ₹4,249 Cr |
How is Operating Profit of CIPLA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,123 Cr | 13.22 | |
| Mar2025 | ₹6,291 Cr | 26.07 | |
| Mar2024 | ₹4,990 Cr | 10.60 | |
| Mar2023 | ₹4,512 Cr | 6.20 | |
| Mar2022 | ₹4,249 Cr | - | |
Compare Operating Profit of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹111,894.2 Cr | 1.8% | -3.7% | -11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,196.0 Cr | 1.8% | -1.7% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹250,390.0 Cr | 2.6% | 9.8% | 54.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,967.0 Cr | 2.4% | -0.5% | 36% | Stock Analytics | |
| MANKIND PHARMA | ₹100,364.0 Cr | 6.2% | 1.9% | -10.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,329.0 Cr | 4.5% | 1.8% | -10% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.8% |
-3.7% |
-11.4% |
| SENSEX | 0.1% |
-2.7% |
-8.6% |
You may also like the below Video Courses